AviadoBio’s $80 Million Series A Financing

Bristows advised AviadoBio’s seed investors.AviadoBio raised $80 million in Series A financing to advance neurodegenerative gene therapy platform. AviadoBio is a pioneering gene therapy company focused on…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Giulia Di Palma

Author: Giulia Di Palma

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here